I’ve been working with the AXIS UK team on a NICE and SMC submission since September 2024. AXIS have been a trusted partner throughout and have consistently provided expert advice and new perspectives that have undoubtedly strengthened our submissions. Carl’s strategic insights from his time at NICE have been invaluable and he is a real asset to the team. Sam, Helen and Annie also have a wealth of experience and have worked tirelessly to provide high quality deliverables and proactively offer advice and solutions. Importantly, the team are friendly and reliable, making them a pleasure to work with day-to-day. I would highly recommend AXIS as a partner for NICE and SMC submissions, and wouldn’t hesitate to work with them again

We partnered with AXIS as we navigated the complex landscape of market access in the UK for a multi-indication oncology product. From the outset, the AXIS team demonstrated strong expertise, conducting rigorous analyses of the options for reimbursement, encompassing landscape reviews, meticulous SWOT analyses and early pricing models which informed the backbone of our market access strategy. During our preparations for the Health Technology Assessment (HTA) submissions for NICE and SMC, the operational support provided was exceptional. Leveraging their deep understanding of the complexities involved in the HTA processes, the nuances of both agencies’ requirements and their key decision-making criteria, they crafted compelling submissions, delivered on time and to agreed budgets. We highly recommend AXIS to any organisation seeking expert support to navigate the complexities of market access in the UK with confidence and clarity.

Working with AXIS on my recent NICE submission was an excellent experience. From the very beginning, their team showcased profound expertise in UK HTA practices and a comprehensive understanding of NICE requirements and preferences. Their strategic guidance, scientific rigor, and attention to detail were apparent throughout every phase of the process, resulting in a high-quality submission ahead of the deadline. What truly set AXIS apart was their remarkable flexibility and collaborative approach. They acted as a great sounding board, readily adapting to changes and navigating evolving priorities with professionalism and ease. Their responsiveness under pressure ensured that we were always informed and supported. I would highly recommend AXIS to any company seeking expert support for HTA submissions in the UK and Ireland

I’ve had the pleasure of working with AXIS on a number of our HTA projects over the past few years and their contribution has been consistently outstanding. Throughout the various projects AXIS has provided excellent strategic guidance that helped shape the HTA strategy to agencies such as NICE, SMC and the JCVI – their pragmatic and solutions-focused mindset ensured we made timely and effective decisions. The team at AXIS consistently demonstrated attention to detail across all technical deliverables and the quality of their work throughout the projects reflected their deep expertise in the UK which was coupled with a strong commitment to excellence. I would highly recommend AXIS to anyone looking for strategic, dependable, and high-quality HTA support in the UK and Ireland

Launching in Ireland for the first time, we were faced with numerous challenges in understanding the market access process and navigating the complexities of reimbursement. AXIS were recommended to us, and we couldn’t be more grateful.

AXIS has been an excellent market access partner that guided the Teva team to navigate the complex pathway to reimbursement of their new medicine for migraines. From the development of a robust Rapid Review to the preparation of a full HTA, through strategic pricing discussions with the HSE and the follow-up interactions with the MMP, AXIS were always highly responsive, dependable, detail orientated and dedicated to our success. Their exceptional project management ensured that commitments made were
always delivered on time and to the highest quality”.

I cannot recommend AXIS highly enough. We faced a very challenging reimbursement application process in Ireland, which is a market where the organisation had no prior experience or expertise. AXIS expertly navigated us through a complex procedure with the NCPE and HSE, providing both content and contextual expertise. They ensured that both our clinical and health economic cases were optimised to the local market environment, represented us with local stakeholders, and helped us navigate a difficult price negotiation. The experience was highly collaborative, working with us as part of a cross functional team and not in a client-vendor relationship. The final result was a highly successful reimbursement outcome for an orphan medication that exceeded objectives both in terms of scope and commercial conditions. If you need a local partner in Ireland look no further.